Register Now and Earn up to 11.75 CME/CE Credits Over Two Days

Be the First to Hear the GOLD 2024 Update!

The 2024 GOLD Report will be available in November and contain important updates on:


  • Vaccination, Including RSV
  • Smoking Cessation
  • Interstitial Lung Abnormalities
  • Screening for COPD in Targeted Populations
  • Hyperinflation
  • Spirometry


To learn more about these updates, join your peers for two days of learning and earn up to 11.75 CME/CE credits. During the 2023 GOLD International COPD Conference you will hear GOLD Science Commitee Chair, Dr. Claus Vogelmeier, present "What's New in GOLD 2024", as well as other international experts present the most up to date strategies for managing COPD. Attend virtually or in-person. All registration includes access to the on-demand library for one year!

Register Now!

 

Conference Agenda

Monday, November 13 | 6:00 pm - 9:00pm


Clinical Management for the COPD Practitioner

In-person session; earn up to 2.75 CME/CE credits


Featuring didactic interactive sessions using case studies to highlight the new 2024 GOLD guidelines.


Sessions of Interest Include:


  • LAMA, LABA, ICS, PDE4i, Triple, Dual, Double: Unraveling the Pharmacotherapy Knot
  • COPD Exacerbation: If Not, What Else?
  • Risks of COPD: Smoking, Vaping, E-Cigarettes – Helping Your Patients STOP
  • Diagnosis: How to Diagnose, Stage, and Implement Treatment in Patients with COPD


Newly Added Dinner Symposium: Aerosol Medication Delivery Bootcamp


Developed in collaboration with the COPD Foundation

Tuesday, November 14 | 7:00 am - 5:30 pm


In-depth learning with our popular, full-day program available in-person or virtually.

Earn up to 9.00 CME/CE credits.


  • Breakfast Symposium, Product Theaters
  • Definition and Severity Classification of COPD Exacerbations: Time for a Change?
  • Role of Respiratory Infections in Patients with COPD
  • GOLD 2024
  • Lunch with learning and networking opportunities
  • Reducing Mortality in COPD—Achieving the Holy Grail
  • Assistive Devices in Patients with COPD
  • The Future of COPD

This CME activity is provided by Integrity Continuing Education, Inc.

This CE activity is jointly provided by Global Education Group and Integrity Continuing Education, Inc.. For full CME/CE information, please refer to https://www.goldcopdconference.com. This activity is supported by independent medical educational grants from AstraZeneca Pharmaceuticals, Chiesi USA, Inc., and Viatris™ and Theravance Biopharma®.

Each session includes a Q&A moderated by GOLD.

Your registration includes on-demand access to exhibits and conference sessions for one year after the live event.